25/100 · Low Risk
Sodium Sulfate Adverse Events: Common Mild Reactions
1,477 FDA adverse event reports analyzed
Last updated: 2026-05-12
SODIUM SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS). Based on analysis of 1,477 FDA adverse event reports, SODIUM SULFATE has a safety score of 25 out of 100. This lower score reflects a significant number of adverse event reports, suggesting that patients should discuss potential risks carefully with their healthcare provider. The most commonly reported adverse reactions for SODIUM SULFATE include PAIN, NAUSEA, HEADACHE, DRUG INEFFECTIVE, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SODIUM SULFATE.
Sodium Sulfate has a safety concern score of 25 out of 100, placing it in the low concern category based on analysis of FDA adverse event data. The FDA has received approximately 1,477 adverse event reports for this medication.
The most commonly reported adverse events include Pain, Nausea, Headache. The most common reactions are pain, nausea, and headache, indicating mild to moderate side effects.
The majority of reactions are non-serious, with the majority of reports involving pain and gastrointestinal issues. There is a notable diversity in reactions, suggesting a wide range of potential side effects. The majority of reports are from adults, with the highest number of reports coming from individuals in their 60s and 70s.
Patients taking Sodium Sulfate should monitor for the commonly reported side effects and contact their healthcare provider if they experience any unusual symptoms. Sodium sulfate is generally well-tolerated, but it may interact with other drugs, particularly those affecting electrolyte balance. Warnings should be followed to avoid adverse interactions. This analysis is based on voluntary FDA adverse event reports and should not replace professional medical advice.
Sodium Sulfate received a safety concern score of 25/100 (low concern). The score accounts for 1,477 total adverse event reports and 100 distinct reaction types. This relatively low score suggests a favorable safety profile in reported data.
Adverse event reports by sex: Female: 396, Male: 167. The most frequently reported age groups are age 70 (22 reports), age 65 (17 reports), age 66 (16 reports). These demographics reflect reporting patterns and may not represent the full patient population.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
Sodium sulfate is generally well-tolerated, but it may interact with other drugs, particularly those affecting electrolyte balance. Warnings should be followed to avoid adverse interactions.
If you are taking Sodium Sulfate, here are important things to know. The most commonly reported side effects include pain, nausea, headache, drug ineffective, diarrhoea. While many of these may be mild and temporary, you should contact your healthcare provider if any symptoms are severe or persistent. Monitor for signs of gastrointestinal distress and pain, and report any severe or persistent symptoms to a healthcare provider. Follow the prescribed dosage and instructions to avoid drug ineffectiveness and other potential side effects. If you experience a serious adverse reaction, seek emergency medical attention immediately or call 911. You can report side effects to the FDA's MedWatch program at 1-800-FDA-1088.
The FDA continues to monitor sodium sulfate for safety, and updates will be provided as necessary. Patients should report any adverse reactions to their healthcare provider.
The FDA has received approximately 1,477 adverse event reports associated with Sodium Sulfate. These reports come from healthcare professionals, consumers, and manufacturers through the FDA Adverse Event Reporting System (FAERS). Note that the number of reports does not directly indicate the frequency of side effects, as adverse events are voluntarily reported and may be underrepresented.
The most frequently reported adverse events for Sodium Sulfate include Pain, Nausea, Headache, Drug Ineffective, Diarrhoea. By volume, the top reported reactions are: Pain (47 reports), Nausea (46 reports), Headache (44 reports). These figures reflect FDA adverse event reports and may not represent the true incidence rate of these side effects in all patients taking Sodium Sulfate.
Adverse event reports for Sodium Sulfate break down by patient sex as follows: Female: 396, Male: 167. This distribution reflects reporting patterns rather than actual risk differences between groups. Reporting rates can be influenced by prescribing patterns, disease demographics, and reporting behavior.
The most frequently reported age groups for Sodium Sulfate adverse events are: age 70: 22 reports, age 65: 17 reports, age 66: 16 reports, age 68: 16 reports, age 64: 15 reports. Age-related reporting patterns can reflect both the demographics of the patient population and potential age-related susceptibility to certain side effects.
Beyond the most common reactions, other reported adverse events for Sodium Sulfate include: Fatigue, Off Label Use, Constipation, Malaise, Arthralgia. Less common side effects can still be clinically significant. Patients should report any unusual symptoms to their healthcare provider.
You can report adverse events from Sodium Sulfate to the FDA through their MedWatch program at www.fda.gov/medwatch, by calling 1-800-FDA-1088, or by completing Form FDA 3500. Healthcare professionals, consumers, and manufacturers can all submit reports. Reporting helps the FDA monitor drug safety after approval.
Sodium Sulfate has a safety concern score of 25 out of 100 (low concern). This score is calculated from the ratio of serious to non-serious adverse events, the diversity of reported reactions, and the overall volume of reports relative to usage. The most common reactions are pain, nausea, and headache, indicating mild to moderate side effects.
Key safety signals identified in Sodium Sulfate's adverse event data include: Pain is the most frequently reported reaction, occurring in 3.2% of reports.. Gastrointestinal issues such as nausea, diarrhea, and abdominal pain are also common, appearing in 3.1% of reports each.. There is a significant number of reports related to drug ineffectiveness, indicating potential issues with the product's efficacy.. These signals are derived from patterns in FDA reports and should be discussed with a healthcare provider for personalized assessment.
Sodium sulfate is generally well-tolerated, but it may interact with other drugs, particularly those affecting electrolyte balance. Warnings should be followed to avoid adverse interactions. Always inform your healthcare provider about all medications, supplements, and over-the-counter drugs you are taking before starting Sodium Sulfate.
Monitor for signs of gastrointestinal distress and pain, and report any severe or persistent symptoms to a healthcare provider. Follow the prescribed dosage and instructions to avoid drug ineffectiveness and other potential side effects.
Sodium Sulfate has 1,477 adverse event reports on file with the FDA. The majority of reactions are non-serious, with the majority of reports involving pain and gastrointestinal issues. The volume of reports for Sodium Sulfate reflects both the drug's usage level and the vigilance of the reporting community.
The FDA continues to monitor sodium sulfate for safety, and updates will be provided as necessary. Patients should report any adverse reactions to their healthcare provider. For the most current regulatory information, check the FDA's drug labeling database or consult your pharmacist.
The following drugs share commonly reported adverse reactions with SODIUM SULFATE:
Drugs related to SODIUM SULFATE based on therapeutic use, drug class, or shared indications: